SOR-C13 TFA, an extraordinary and highly specialized inhibitor deployed within the biomedical sphere for the purpose of combating cancer, embodies immense potency. Notably designed to single out sorafenib-resistant cells, it amplifies the efficacy of the widely employed sorafenib drug, primarily acclaimed for its profound impact against advanced renal cell carcinoma and liver malignancies.
CAT# | R2011 |
M.F/Formula | C74H117F3N20O21 |
M.W/Mr. | 1679.84 |
Appearance | Solid |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Figure 1. The structural formula of montirelinMontirelin, an analog of thyrotrophin-releasing hormone (TRH) is m ...
Signal peptides stimulate matrix protein production in general and collagen synthesis in specific. They may be accomplished b ...
BIM 189 is one of the most potent bombesin antagonists known in the guinea pig and 3T3 cell systems but has 40% ...
Figure 1. Chemical structure of lysipressinLysipressin ([Lys8]-vasopressin) has been identified in the North Ame ...
The peptide Difopein, designed, isolated and identified by Haian Fu, is a high affinity inhibitor of 14-3-3 pro ...